Results · Apr-Jun 2026 · filed 14 Aug 2026
Coral Laboratories Q1 FY27 results
Sales grew 57% to ₹29.6 crore from ₹18.8 crore in Apr-Jun 2025.
Operating profit grew 151% to ₹5.5 crore, an operating margin of 18.5% (up 6.9 points from a year ago).
Net profit grew 110% to ₹5.4 crore from ₹2.6 crore in Apr-Jun 2025.
Against Jan-Mar 2026: sales +12%, net profit +3%.
Apr-Jun 2026 vs a year ago
| ₹ crore | Apr-Jun 2026 | Apr-Jun 2025 | Change |
|---|---|---|---|
| Sales | 29.6 | 18.8 | +57% |
| Operating profit (EBITDA) | 5.5 | 2.2 | +151% |
| Operating margin | 18.5% | 11.6% | +6.9 pts |
| Net profit | 5.4 | 2.6 | +110% |
Standalone figures. Margins & ratios change in percentage points (pts).
The last 7 quarters
Filings that week
- 14 Aug 2026Notice Of Book Closure
- 14 Aug 2026Intimation For Holding 44Th AGM
- 14 Aug 2026Financial Results For The Quarter Ended On June 30, 2026
- 14 Aug 2026Notice Of Book Closure And Record Date
- 14 Aug 2026Board Meeting Outcome for Outcome Of Board Meeting
From the company's results filed on BSE (Standalone). Business numbers only. Education & analysis, not investment advice or a recommendation.